ESC Premium Access

Introduction - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.

logo

Congress Presentation

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
31 presentations
1 follower

5 more presentations in this session

Safety of non-vitamin K antagonist oral anticoagulants - Considerations for management of atrial fibrillation patients .

Speaker: Doctor C. Ruff (Boston, US)

Thumbnail

Implication of the new EHRA practical guide for the treatment of atrial fibrillation patients.

Speaker: Professor J. Steffel (Zurich, CH)

Thumbnail

Complementing results from randomised trials: the value of international observational studies.

Speaker: Professor P. Kirchhof (Hamburg, DE)

Thumbnail

Panel discussion - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Summary and close - Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice.

Speaker: Professor P. Kirchhof (Hamburg, DE)

Thumbnail

Access the full session

Oral anticoagulation in atrial fibrillation - From evidence-based medicine to daily clinical practice

Speakers: Doctor J. Weitz, Doctor C. Ruff, Professor J. Steffel, Professor P. Kirchhof, Doctor J. Weitz...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by